Rifampin-resistant tuberculosis Clinical Trials
Conditions / Rifampin-resistant tuberculosis
Delta Trials catalogs 2 clinical trials for Rifampin-resistant tuberculosis in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 0 trials have reached completion. This research occurs across 31 participating sites around the world. An additional 1 trial are in other active phases such as not yet recruiting or pending status. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
2
Total Trials
1
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
31
Study Locations
Browse by location (31 total)
- Changsha, China 1 trialAll trials in Changsha, China
- Beijing, China 1 trialAll trials in Beijing, China
- Jinan, China 1 trialAll trials in Jinan, China
- East London, South Africa 1 trialAll trials in East London, South Africa
- Linyi, China 1 trialAll trials in Linyi, China
- Wenzhou, China 1 trialAll trials in Wenzhou, China
- Taiyuan, China 1 trialAll trials in Taiyuan, China
- Zhengzhou, China 1 trialAll trials in Zhengzhou, China
- Jinan, China 1 trialAll trials in Jinan, China
- Liupanshui, China 1 trialAll trials in Liupanshui, China
- Xiamen, China 1 trialAll trials in Xiamen, China
- Shanghai, China 1 trialAll trials in Shanghai, China
- Jilin, China 1 trialAll trials in Jilin, China
- Shenyang, China 1 trialAll trials in Shenyang, China
- Nanning, China 1 trialAll trials in Nanning, China
- Shijiazhuang, China 1 trialAll trials in Shijiazhuang, China
- Xinxiang, China 1 trialAll trials in Xinxiang, China
- Harbin, China 1 trialAll trials in Harbin, China
- Chengdu, China 1 trialAll trials in Chengdu, China
- Qingdao, China 1 trialAll trials in Qingdao, China